Why do some transnational advocacy movements have more success transforming global markets than others? Can we look to look to differences in market structure for a preliminary account? Why were AIDS advocates able to achieve extended access to antiretroviral medications for millions of people while climate campaigners have struggled to achieve comparable gains?
This week, International Studies Quarterly published an early access and ungated version of my article with Ethan Kapstein where we examine how the structure of markets shaped the differential scope for climate and AIDS advocacy. (This is an extension of our 2013 book AIDS Drugs for All which had a broader focus on movement organization and agency.)
In brief, we argue that four factors of the industry opportunity structure facilitate market transformation: (1) the number of product markets, (2) the degree of global integration (3) market concentration and (4) the source of rents. In this post, I thought I’d walk through the logic we develop in the article and some of the issues that I think merit further research. (I developed some of these themes in my remarks at last fall’s APSA pre-conference workshop on markets and politics). Continue reading